Navigation Links
Baxa Corporation Launches New Web Site
Date:1/31/2008

ENGLEWOOD, Colo., Jan. 31 /PRNewswire/ -- Baxa Corporation announces the launch of its new corporate Web site. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. The site redesign updates the baxa.com infrastructure to support more frequent content updates and the addition of multimedia materials and interactive training tools. The new Baxa site addresses customer feedback on desired site content and was developed to provide a better user experience through increased technical content and more in-depth product specification and demonstration materials.

"By updating the site's functionality and page layouts, the redesign allowed us to improve the user experience. Its new search capabilities and content management make it faster to find and access what our visitors are looking for," notes Marian Robinson, Baxa VP of Marketing. Baxa.com provides a wide variety of complimentary training tools and technical and clinical resources that help users understand regulatory requirements, compliance guidelines and industry trends and best practices. A unique feature of the new Baxa site is its information cart facility, which allows users to 'order' documents on the site then download them to their desktops with just a click.

Baxa Corporation markets and sells medical devices for use in health-system pharmacies and for patient care. Its OEM group provides specialty products for packaging with prescription pharmaceuticals. For more information about Baxa, or to demonstrate the new Web site features, visit http://www.baxa.com

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CuraGen Corporation Receives Notification from NASDAQ
2. Healionics Corporation Completes Series A Financing
3. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
4. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
5. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
6. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
7. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
8. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
9. Pharmos Corporation Completes Initial Closing of Private Placement
10. Pharmos Corporation Announces Board and Management Changes
11. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Research and Markets has ... report to their offering. ... The Global Market for Bioproducts ... 2016 at a CAGR of 8.9%, This ... bioproducts into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals ...
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... 23, 2017  BioPharmX Corporation (NYSE MKT: BPMX), ... dermatology market, today reported financial results for the ... will provide an update on the company,s clinical ... "We are pleased to report that last ... said President Anja Krammer. "We achieved key clinical ...
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all the information you ... activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , ... software globally, announces significant enhancements to new and core ... 2016. New products include mobile and desktop Acuant FRM ... TM - a real time manual review of ... idScan® technology provides the fastest and most accurate capture ...
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
Breaking Biology News(10 mins):